CN Patent

CN111870591B — 一种控制乙酰半胱氨酸溶液硫化氢含量的方法

Assigned to Star Pharmaceutical Ltd · Expires 2022-07-26 · 4y expired

What this patent protects

本发明提供一种控制乙酰半胱氨酸溶液硫化氢含量的方法。本发明采用无菌生产工艺生产吸入用乙酰半胱氨酸溶液，与进口药富露施的灭菌生产工艺相比，对硫化氢有较好的控制效果，本发明工艺生产的吸入用乙酰半胱氨酸溶液中硫化氢的含量不大于100ppm。本发明提供的吸入用乙酰半胱氨酸溶液，处方选择合理，生产工艺安全可控，成品质量稳定。

USPTO Abstract

本发明提供一种控制乙酰半胱氨酸溶液硫化氢含量的方法。本发明采用无菌生产工艺生产吸入用乙酰半胱氨酸溶液，与进口药富露施的灭菌生产工艺相比，对硫化氢有较好的控制效果，本发明工艺生产的吸入用乙酰半胱氨酸溶液中硫化氢的含量不大于100ppm。本发明提供的吸入用乙酰半胱氨酸溶液，处方选择合理，生产工艺安全可控，成品质量稳定。

Drugs covered by this patent

Patent Metadata

Patent number
CN111870591B
Jurisdiction
CN
Classification
—
Expires
2022-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Star Pharmaceutical Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.